Go back
Body SystemsPancreas
Other Names
Synopsis
Pancreas
Overview and Definition
The pancreas is an organ of the digestive system and endocrine system of vertebrates. In humans, it is located in the abdomen behind the stomach and functions as a gland. The pancreas is a mixed or heterocrine gland — it has both an endocrine and a digestive exocrine function. Ninety-nine percent of the pancreatic tissue is exocrine; only 1% is endocrine. As an endocrine gland, it functions mostly to regulate blood sugar levels, secreting the hormones insulin, glucagon, somatostatin, and pancreatic polypeptide. As a part of the digestive system, it functions as an exocrine gland, secreting pancreatic juice into the duodenum through the pancreatic duct.
Complex interactions and signaling mechanisms between the endocrine and exocrine functions of the pancreas play a crucial role in maintaining metabolic homeostasis and overall health. Compelling evidence indicates direct and indirect crosstalk between the endocrine and exocrine parts, influencing the development of diseases affecting both.
Anatomy and Structural Components
Gross Anatomy
The pancreas is a long, slender organ, most of which is located posterior to the bottom half of the stomach. It is a soft, finely lobulated retroperitoneal gland on the posterior abdominal wall. More specifically, it is located in the upper epigastrium and left hypochondriac regions of the abdomen.
Exocrine Compartment
The pancreas is a mixed gland with both exocrine and endocrine components. The exocrine portion comprises approximately 85% of pancreatic mass and is organised into lobules of secretory acinar cells and a branching duct system. Scattered between the acini are islets of Langerhans, which form the endocrine pancreas.
The functional unit of the exocrine pancreas consists of an acinus and its associated duct system. Acinar cells specialise in the synthesis, storage, and secretion of digestive enzymes. Ductal cells secrete bicarbonate and water, modifying the aqueous component of pancreatic juice.
The acinar cell of the exocrine pancreas has the greatest rate of protein synthesis of any mammalian organ. The acinar cell has a highly developed endoplasmic reticulum (ER) system combined with mechanisms to modify and transport newly synthesized proteins through the secretory pathway. In addition to its functions in performing protein synthesis and processing, the ER is the major storage site for intracellular calcium, which, when released into the cytoplasm, is the mediator of regulated secretion of stored digestive enzymes into the pancreatic ductal system.
Endocrine Compartment: The Islets of Langerhans
Although the pancreas is primarily an exocrine gland, it has an important endocrine function. Its pancreatic islets — clusters of cells formerly known as the islets of Langerhans — secrete the hormones glucagon, insulin, somatostatin, and pancreatic polypeptide (PP).
The endocrine pancreas consists of the islets of Langerhans. There are approximately one million islets that weigh about 1 gram in total and are scattered throughout the pancreas. The cells that make up the islets arise from both endodermal and neuroectodermal precursor cells.
The endocrine portion is arranged as discrete islets of Langerhans, composed of five endocrine cell types — alpha, beta, delta, epsilon, and upsilon — that secrete at least five hormones, including glucagon, insulin, somatostatin, ghrelin, and pancreatic polypeptide, respectively.
The islets of Langerhans contain alpha, beta, and delta cells that produce glucagon, insulin, and somatostatin, respectively. A fourth type of islet cell, the PP (or F) cell, is located at the periphery of the islets and secretes pancreatic polypeptide. These hormones regulate one another's secretion through paracrine cell-cell interactions.
Vascular Supply and Endo-Exocrine Crosstalk
Arterial blood enters the pancreas via branches of pancreaticoduodenal arteries and splenic arteries, which further divide into a network of arterioles and capillaries, first entering the islets of Langerhans. This blood supply route from the islets to the exocrine part ensures that endocrine hormones such as insulin and glucagon can directly affect the function of exocrine cells and coordinate the overall function of the pancreas.
Physiological Functions
Exocrine Function: Digestion
The exocrine pancreas supports digestion through secretion of digestive enzymes and an alkaline, bicarbonate-rich fluid. Together, these facilitate the breakdown of carbohydrates, proteins, and lipids, and neutralise gastric acid.
The exocrine pancreas produces three main types of enzymes: amylase, protease, and lipase. The four major enzyme groups are proteolytic (e.g., chymotrypsin), amylolytic (e.g., amylase), lipolytic (e.g., lipase), and nuclease digestive enzymes. Under normal physiologic conditions, lipase breaks undigested triglycerides into fatty acids and monoglycerides. Bile salts then solubilize these breakdown products to form micelles, which are vehicles for absorbing lipid breakdown products.
Pancreatic exocrine secretions, nearly 2.5 L per day in volume, can be classified in two groups: organic and inorganic. Organic secretions are proteins such as digestive enzymes; inorganic secretions consist mostly of water and electrolytes. Acinar cells secrete digestive enzymes and ductal cells secrete a bicarbonate-rich electrolyte solution.
Pancreatic secretion is governed by neural and hormonal mechanisms. The hormones responsible for regulation are secretin and cholecystokinin (CCK). Secretin is secreted in response to acid in the duodenum, causing duct cells to release water and bicarbonate; CCK is secreted in response to protein and fat in the small intestine, stimulating acinar cells to release the pancreatic enzymes.
Amylase exhibits broad tissue distribution, with the highest P-type activity located in the exocrine pancreas. P-type amylase is synthesized by pancreatic acinar cells and secreted into the intestinal tract via the pancreatic duct system.
Endocrine Function: Glucose and Metabolic Homeostasis
The endocrine pancreas produces several hormones that work together to regulate glucose homeostasis, energy storage, and metabolism. Insulin, glucagon, amylin, somatostatin, ghrelin, and pancreatic polypeptide are secreted by specialized islet cells and exert coordinated effects on target tissues.
Hormones regulate both the storage and the utilization of glucose as required. Receptors located in the pancreas sense blood glucose levels, and subsequently the pancreatic cells secrete glucagon or insulin to maintain normal levels.
The importance of the endocrine pancreas lies in the fact that insulin plays a central role in the regulation of energy metabolism. A relative or absolute deficiency of insulin leads to diabetes mellitus, which is a major cause of disease and death throughout the world.
The pancreatic islet cell types include alpha cells, which produce glucagon; beta cells, which produce insulin; delta cells, which produce somatostatin; and PP cells, which produce pancreatic polypeptide.
The PP cell accounts for about one percent of islet cells and secretes the pancreatic polypeptide hormone. It is thought to play a role in appetite, as well as in the regulation of pancreatic exocrine and endocrine secretions. Pancreatic polypeptide released following a meal may reduce further food consumption; however, it is also released in response to fasting.
From a developmental perspective, the exocrine and endocrine parts share the same origin — the "tip-trunk" domain. In certain circumstances, pancreatic exocrine cells may transdifferentiate into endocrine-like cells, such as insulin-secreting cells.
Assessment of Pancreatic Health
Laboratory Tests
Health care professionals may use lab or imaging tests to diagnose pancreatitis and find its causes. Diagnosing chronic pancreatitis can be hard in the early stages. Doctors will also test for other conditions that have similar symptoms, such as peptic ulcers or pancreatic cancer.
Lab tests to help diagnose pancreatitis include blood tests, in which a health care professional may test for high amylase and lipase levels — digestive enzymes made in the pancreas — as well as stool tests to find out if a person has fat malabsorption.
The currently commonly used laboratory tests in the diagnosis of acute pancreatitis are serum lipase and serum amylase. Based on multiple studies, lipase serum has been found to be a more reliable indicator of acute pancreatitis than serum amylase.
Amylase has historically played a central role in diagnosing acute pancreatitis. Assessment may be performed via blood or urine testing.
Imaging Tests
Ultrasonography is recommended as a first and basic imaging test performed in patients with suspected acute pancreatitis in order to confirm or exclude the diagnosis as well as detect the possible cause of the disease, while MRI and CT are useful in diagnosing local complications and discovering necrosis of the pancreas or in assessing severity. The latter two are performed to broaden the diagnosis or when ultrasound does not visualize the structures properly.
Health care professionals use MRCP (magnetic resonance cholangiopancreatography) to look at the pancreas, gallbladder, and bile ducts for causes of pancreatitis. Endoscopic ultrasound (EUS) involves inserting an endoscope — a thin, flexible tube — down the throat, through the stomach, and into the small intestine, where an ultrasound attachment creates pictures of the pancreas and bile ducts.
Functional Tests
The Pancreatic Function Test (PFT) measures how the pancreas responds to secretin, a hormone made by the small intestine. This test is performed only at some specialized centers in the United States.
To diagnose exocrine pancreatic insufficiency (EPI), doctors ask about medical and family history, perform a physical exam, and order tests, including inquiry about history of excessive alcohol consumption and history of smoking, which may increase the chance of developing pancreatitis and pancreatic cancer. During a pancreatic function test, health care professionals give intravenous secretin and insert a tube through the nose and into the small intestine to collect fluid samples for lab analysis.
Several non-invasive tests are available to assess pancreatic function, but none is routinely used in clinical practice to diagnose chronic pancreatitis due to poor sensitivity in diagnosing mild pancreatic insufficiency. The mixed triglyceride breath test seems to be useful in finding the correct dosage of enzyme substitutive therapy to prevent malnutrition in patients with known pancreatic insufficiency.
Emerging Diagnostic Markers
Pancreatic ductal adenocarcinoma (PDAC) accounts for the vast majority of pancreatic cancers. It is one of the leading causes of cancer death in the United States because the survival rate is very low. Only about 1 in 10 patients with pancreatic cancer survive longer than five years after diagnosis. Part of why it is so deadly is that it is usually diagnosed too late for treatment to be effective.
Researchers have identified two new markers in blood that were higher in people with early-stage pancreatic cancer than in healthy patients: aminopeptidase N (ANPEP) and polymeric immunoglobin receptor (PIGR). A combined test was developed that looks for ANPEP and PIGR along with CA19-9 and THBS2.
Conditions and Diseases Associated with the Pancreas
Acute Pancreatitis
Acute pancreatitis (AP) is a rapid inflammatory disease of the pancreas with a variety of clinical and morphological presentations. Patients present with onset of sudden severe epigastric pain that often radiates to the back, abdominal pain that gets worse after eating, abdominal tenderness, nausea, vomiting, fever, and rapid pulse. Diagnosis is confirmed if at least two of the three criteria are satisfied: abdominal pain; serum lipase or amylase levels at least three times the upper physiological limit; and/or radiographic evidence of acute pancreatitis.
Relapsing or chronic pancreatitis can lead to exocrine and endocrine pancreatic insufficiency. Major causes of pancreatitis are alcohol use, cholelithiasis, drug toxicity, and infections. In some cases there may be a genetic basis; however, a significant percentage of cases are idiopathic.
Chronic Pancreatitis
Chronic pancreatitis is a disease that leads to irreversible changes in the pancreatic morphology and function. The loss of function can lead to diabetes mellitus and exocrine pancreatic insufficiency. The inflammation and fibrosis can also lead to other complications including a chronic abdominal pain syndrome, metabolic bone disease, and pancreatic cancer.
Chronic pancreatitis is a fibro-inflammatory disease that can produce complications through loss of endocrine function, loss of exocrine function, and compromise of the local vascular and luminal anatomy. The primary complications include abdominal pain, diabetes mellitus, exocrine pancreatic insufficiency (namely fat malabsorption), metabolic bone disease, and pancreatic cancer. Additional anatomic complications can include pseudocysts, splanchnic venous thrombosis, and duodenal or biliary obstruction.
As there are currently no treatments to reverse or delay disease progression in chronic pancreatitis, the clinical management primarily consists of screening for and treating complications.
Exocrine Pancreatic Insufficiency (EPI)
Exocrine pancreatic insufficiency (EPI) is a reduction in pancreatic enzyme activity — primarily pancreatic lipase — within the intestinal lumen below the threshold required for digestive functions. EPI may result from inadequate stimulation of secretion, reduced acinar enzyme secretion, obstruction of the pancreatic duct outflow, or inadequate mixing of pancreatic enzymes with ingested food.
Patients with EPI commonly present with steatorrhea, flatulence, weight loss, and abdominal pain of variable location and severity. EPI is associated with impaired quality of life, increased risk of complications due to malnutrition, low bone mineral density, and functional decline.
Although the most common cause of EPI is chronic pancreatitis, several other causes also result in EPI. These include pancreatic tumors, pancreas resection, and cystic fibrosis. Other diseases and conditions, such as diabetes, celiac disease, inflammatory bowel diseases, and advanced patient age, have also been shown to be associated with EPI, but the exact etiology of EPI has not been clearly elucidated in these situations.
Pancreatic enzyme replacement therapy (PERT) is the primary treatment of EPI. A combination of pancreatic enzymes — lipase, amylase, and protease — prevents malabsorption and restores the normal physiologic digestive process. The enteric coating of the enzymatic supplement protects from gastric acidity, allowing for dissolution in the duodenum in response to an alkaline pH.
Pancreatogenic Diabetes (Type 3c Diabetes Mellitus)
In recurrent acute or chronic pancreatitis and in cystic fibrosis, the development of exocrine insufficiency typically predates the development of endocrine insufficiency and diabetes. Any episode of acute pancreatitis can cause a transient diabetic state and increases the risk of the subsequent development of diabetes.
The pathophysiology of type 3c diabetes most commonly involves pancreatic glandular inflammation and subsequent irreversible fibrotic damage leading to islet cell loss. Unlike other types of diabetes, the islet loss involves not only the β-cells but also the pancreatic polypeptide (PP) cells early in the disease course and the α-cells late in the disease course.
Because of concomitant pancreatic exocrine insufficiency, there is also maldigestion of nutrients with consequent impairment in incretin secretion, and pancreatic enzyme replacement can improve incretin and insulin secretion as well as glucose tolerance. Typically, islet β-cell secretory capacity is preserved until the majority of pancreatic exocrine function is lost; however, traditional type 2 diabetes risk factors and insulin resistance may accelerate the presentation of diabetes in the context of pancreatic disease.
Pancreatic Cancer
Inflammation and fibrosis caused by chronic pancreatitis exacerbate malignant transformation and significantly increase the risk of developing pancreatic cancer, the world's most aggressive cancer with a 5-year survival rate less than 10%.
Several pancreatic diseases, including pancreatic cancer, pancreatitis, and diabetes, exhibit potential relevance to both endocrine and exocrine functions. Endocrine cells may communicate with exocrine cells directly through cytokines or indirectly by regulating the immune microenvironment. This crosstalk affects the onset and progression of these diseases.
Cystic Fibrosis and the Pancreas
Bicarbonate secretion by pancreatic ductal cells depends on the cystic fibrosis transmembrane conductance regulator (CFTR), which supports bicarbonate transport into the duct in exchange for chloride. In cystic fibrosis, defective CFTR reduces bicarbonate and water secretion, producing thick secretions that obstruct the pancreatic ducts. This predisposes to ductal blockage, inflammation, and progressive damage to pancreatic tissue.
Nutrients, Herbs, and Natural Ingredients Studied in Relation to Pancreatic Function
The following section covers micronutrients and botanical compounds that have been studied or traditionally used in connection with pancreatic or pancreas-related metabolic function. A strict distinction is made between historical or traditional use and the scientific evidence available from clinical studies.
Zinc
Physiological Role
Zinc (Zn²⁺) is an essential element crucial for growth and development, and also plays a role in cell signaling. In the mammalian pancreas, Zn²⁺ is essential for the correct processing, storage, secretion, and action of insulin in beta (β)-cells. Insulin is stored inside secretory vesicles or granules, where two Zn²⁺ ions coordinate six insulin monomers to form the hexameric structure on which maturated insulin crystals are based.
Because abnormal zinc homeostasis causes diabetes, and because the pancreatic β-cell contains the highest zinc content of any known cell type, it is of particular interest to understand how zinc fluxes are controlled in β-cells. The understanding of zinc homeostasis has been boosted by the discovery of multiprotein families of zinc transporters, and one of them — zinc transporter 8 (ZnT8) — is abundantly and specifically expressed in the pancreatic islets of Langerhans. Evidence supports a physiological role of ZnT8 in the formation of zinc-insulin crystals, the physical form in which most insulin is stored in secretory granules.
ZNT8 is mainly expressed in β-cells and functions to deliver zinc into granules for insulin maturation and secretion. Many other zinc transporters are also expressed in β-cells. Defects in these zinc transporters have been associated with abnormalities in insulin synthesis, maturation, and secretion and subsequent glucose metabolism.
Scientific Evidence
Lowered circulating levels of zinc are also found in diabetes mellitus. Zn²⁺ ions are essential for a huge range of cellular functions and, in the specialized pancreatic β-cell, for the storage of insulin within the secretory granule. Genetic variants in the SLC30A8 gene, which encodes the diabetes-associated granule-resident Zn²⁺ transporter ZnT8, are associated with an altered risk of type 2 diabetes. This represents an important line of evidence linking zinc biology to diabetes susceptibility. The body of evidence is primarily molecular, genetic, and cell-based; large-scale human interventional trials specifically targeting pancreatic β-cell zinc levels remain limited.
Magnesium
Physiological Role and Scientific Evidence
Studies have demonstrated that magnesium deficiency is associated with reduced pancreatic β-cell activity and increased insulin resistance in patients with type 2 diabetes. Additionally, magnesium is involved in many cellular events, including energy homeostasis, protein synthesis, and DNA stability. Furthermore, magnesium is critical for proper glucose utilization and insulin signaling, and magnesium deficiency can lead to the dysregulation of ATP-sensitive potassium (KATP) channels in pancreatic β-cells, impairing insulin secretion.
Intracellular magnesium concentrations are essential for optimal insulin receptor bioactivity and downstream signaling events in target cells. Low magnesium levels contribute to impaired tyrosine kinase activities of insulin receptors, causing altered cellular glucose utilization and eventual insulin resistance. An increased incidence of hypomagnesemia has been reported in patients with type 2 diabetes.
Numerous clinical studies have documented the benefits of magnesium supplementation on the metabolic profiles of patients with diabetes. However, most evidence pertains to general glucose metabolism and insulin sensitivity rather than direct pancreatic structural outcomes, and the overall strength of evidence for magnesium supplementation in non-deficient individuals remains moderate. Correction of established hypomagnesemia appears better supported than supplementation in replete individuals.
Chromium
Physiological Role
Insulin is secreted by specialized cells in the pancreas in response to increased blood glucose concentration. Insulin binds to insulin receptors on the surface of cells, activating the receptors and stimulating glucose uptake by cells. Through its interaction with insulin receptors, insulin provides cells with glucose for energy and helps maintain blood glucose within a narrow range of concentrations.
Certain alterations in insulin secretion and actions can be related to a decrease in chromium (Cr) or zinc (Zn) levels. Both chromium and zinc demonstrate action on basic cellular reactions of carbohydrates, lipids, protein metabolism, and energy production.
Scientific Evidence
A decreased response to insulin or decreased insulin sensitivity in peripheral tissues — adipose tissue, muscle, and liver — and a progressive defect in insulin secretion may result in impaired glucose tolerance, frequently leading to overt type 2 diabetes mellitus. The body initially increases the secretion of insulin by specialized pancreatic cells to overcome the decrease in insulin sensitivity. Chromium is hypothesized to act at the level of insulin receptor signaling rather than directly enhancing insulin secretion by the pancreas itself. Evidence from human trials is mixed, and the Linus Pauling Institute at Oregon State University notes that the mechanistic picture and evidence base for chromium in glucose metabolism remains the subject of ongoing research.
Berberine
Traditional Use
Berberine (BBR) is a naturally occurring plant-derived polyphenol present in a variety of herbal remedies used in traditional medicine to treat ulcers, infections, jaundice, and inflammation. The herb Rhizoma Coptidis (Huanglian) has been frequently used in many traditional Chinese formulas for the treatment of diabetes mellitus over thousands of years. Berberine, the main active component, has been demonstrated to have potential hypoglycemic effects.
Scientific Evidence — Metabolic Effects
To determine the potential advantages of berberine for diabetic care, a systematic review and meta-analysis was conducted to examine the efficacy and safety of berberine in the treatment of patients with type 2 diabetes. Eight databases including PubMed, Embase, the Cochrane Library, and others were searched for randomized controlled trials reporting clinical data regarding the use of berberine.
At present, most of the clinical treatment strategies and meta-analyses for metabolic disorders show that combined medicines with berberine ameliorate several metabolic disorders. However, evidence to disclose the therapeutic effect of berberine treatment alone and the possible factors affecting the efficacy is limited. Evidence from RCTs suggests that berberine can reduce fasting blood glucose and HbA1c in type 2 diabetes, though most trials are of short duration, primarily conducted in Chinese populations, and subject to risk-of-bias concerns.
Scientific Evidence — Pancreatitis and Pancreatic Cancer (Preclinical)
Current reviews summarize existing in vitro and in vivo evidence on the effects of berberine against pancreatitis and pancreatic cancer, with a focus on the signaling mechanisms underlying the effects of berberine. This evidence is preclinical only.
Berberine was shown to restore p16 and p21 function in pancreatic intraepithelial neoplasia (PanIN). Berberine increased AMP-activated protein kinase (AMPK) and apoptosis signaling, and decreased oncogenic KRAS, ERK, mTOR, and p70S6K signaling, culminating in decreased proliferation and survival and increased apoptosis, cytostasis, and autophagy.
Treatment of pancreatic ductal adenocarcinoma (PDAC) cells with berberine inhibited DNA synthesis and proliferation, and delayed the progression of their cell cycle in G1. Berberine treatment also reduced (by 70%) the growth of MiaPaCa-2 cells when implanted into mice. Mechanistic studies revealed that berberine decreased mitochondrial membrane potential and intracellular ATP levels and induced potent AMPK activation. Furthermore, berberine dose-dependently inhibited mTORC1 and ERK activation in PDAC cells. These findings are in vitro and in animal models; no controlled human clinical trials have established efficacy of berberine against pancreatitis or pancreatic cancer in humans.
Bitter Melon (Momordica charantia)
Traditional Use
Bitter melon (Momordica charantia) has a long history of use in traditional medicine across Asia, Africa, and the Caribbean as an antidiabetic food and herbal remedy. It has been consumed as a vegetable and prepared as juice, decoctions, and extracts to manage blood glucose levels in traditional Ayurvedic, Chinese, and folk medicine systems.
Scientific Evidence
Several studies have shown that Momordica charantia (bitter melon) may have beneficial effects on metabolic syndrome parameters and exerts antidiabetic, anti-hyperlipidemic, and anti-obesity activities. Since the findings of these studies are contradictory, systematic reviews and meta-analyses have been conducted to assess the efficacy of bitter melon in the treatment of metabolic syndrome, with special emphasis on the anti-diabetic effect.
A meta-analysis included nine studies with 414 patients in total and 4–16 weeks of follow-up. In the meta-analysis of change scores, no significant effect could be observed for bitter melon treatment over placebo on fasting blood glucose level, HbA1c level, HDL, LDL, total cholesterol, body weight, BMI, systolic blood pressure, or diastolic blood pressure levels.
The most important limitation of this meta-analysis is that the number of included studies and the number of patients is low, making even the meta-analysis underpowered; moreover, the applied doses were not uniform. Although unambiguous efficacy was not found in any of the analyzed outcomes, bitter gourd was found to be effective in some individual clinical trials. The duration of studies (4–16 weeks) was too short to reveal the potential effects on metabolic parameters. This highlights the need for additional research in carefully planned clinical trials.
Although it has been suggested that bitter melon promotes post-meal insulin secretion, thereby improving glycemic response, this has only been shown in a single-dose experiment without a control group, and this mechanism of activity may require the presence of viable pancreatic β cells to secrete insulin. Overall, the current clinical evidence for bitter melon is insufficient to support a definitive conclusion about its effects on glucose control.
Curcumin
Traditional Use
Curcumin is the principal polyphenolic compound in turmeric (Curcuma longa), a spice used for millennia in Ayurvedic and traditional Chinese medicine for conditions including inflammation, digestive disorders, and jaundice. Its relationship to pancreatic disease in traditional contexts was largely secondary to its general anti-inflammatory and digestive applications.
Scientific Evidence — Pancreatic Cancer (Preclinical and Early Clinical)
Several preclinical studies have demonstrated that curcumin, a naturally occurring polyphenolic compound, has anticancer effects against different types of cancer, including pancreatic cancer (PC), by modulating many molecular targets. In vitro studies have shown potent cytotoxic effects of curcumin on different PC cell lines.
Curcumin has anticancer effects both alone and in combination with other anticancer drugs such as gemcitabine, 5-fluorouracil, and oxaliplatin, and it has been shown to modulate a variety of molecular targets in preclinical models, with more than 30 molecular targets identified to date. Of these, NF-κB is thought to be one of the primary targets of curcumin activity.
Based on promising preclinical results, several research groups have progressed to testing the anticancer effects of curcumin in clinical trials; however, the poor bioavailability of curcumin has been the major challenge for its clinical application. Despite the ingestion of gram-level doses of curcumin, plasma curcumin levels remain at low (ng/mL) levels in patients, which is insufficient to yield the potential anticancer benefits of curcumin.
This problem has been partially addressed by the development of highly bioavailable forms of curcumin, and higher plasma curcumin levels can now be achieved without increased toxicity. Further clinical trials will be necessary to test the therapeutic applications of curcumin in patients with pancreatic cancer. As of current evidence, curcumin's effects in pancreatic cancer are primarily preclinical; it cannot be considered an established clinical treatment.
Summary of Evidence Strength
- Zinc: Strong mechanistic and molecular evidence for an essential physiological role in pancreatic β-cell insulin storage and secretion. Genetic epidemiological data (ZnT8 variants) links zinc homeostasis to type 2 diabetes risk. Clinical supplementation trials are limited and do not yet establish therapeutic doses for direct pancreatic benefit beyond correcting frank deficiency.
- Magnesium: Well-documented association between hypomagnesemia and impaired pancreatic β-cell function, with numerous clinical studies supporting benefits on metabolic profiles in deficient individuals. Evidence is strongest for correction of deficiency; evidence for supplementation in replete individuals is weaker.
- Chromium: Preliminary to moderate evidence from human trials suggesting a role in insulin sensitivity; the direct relationship to pancreatic secretory function is indirect. Evidence base is mixed, with ongoing debate over mechanisms and clinical significance.
- Berberine: Moderate-strength evidence from RCTs (many with methodological limitations) for glycemic benefit in type 2 diabetes. Evidence for effects on pancreatitis and pancreatic cancer is preclinical only (in vitro and animal models).
- Bitter Melon (M. charantia): Traditional use is well-documented across multiple cultures; clinical trial results are conflicting and current meta-analyses do not support a definitive conclusion. Evidence strength: weak to insufficient based on available RCTs.
- Curcumin: Extensive preclinical evidence for anticancer effects in pancreatic cancer cell lines and animal models. Clinical translation is limited primarily by very poor bioavailability; clinical evidence remains preliminary and insufficient to establish therapeutic use.
References
- Physiology, Pancreas — StatPearls, NCBI Bookshelf (NIH)
- The Endocrine Pancreas — Anatomy and Physiology 2e, OpenStax
- Pancreatic Endocrine and Exocrine Signaling and Crosstalk — PMC/Signal Transduction and Targeted Therapy (2025)
- Diagnosis of Pancreatitis — NIDDK, National Institutes of Health
- Exocrine Pancreatic Insufficiency (EPI) — NIDDK, National Institutes of Health
- Diagnosis for Exocrine Pancreatic Insufficiency — NIDDK, National Institutes of Health
- Symptoms & Causes for Exocrine Pancreatic Insufficiency — NIDDK, National Institutes of Health
- Diagnosis and Treatment of Acute Pancreatitis — PMC (2022)
- Complications of Chronic Pancreatitis — PMC (2017)
- Causes of Exocrine Pancreatic Insufficiency Other Than Chronic Pancreatitis — PMC (2022)
- Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer — PMC (2017)
- Progress toward a Blood Test for Early Pancreatic Cancer — NIH (2026)
- Exocrine Pancreatic Insufficiency — StatPearls, NCBI Bookshelf (NIH)
- Digestive Enzymes — The Exocrine Pancreas, NCBI Bookshelf (NIH)
- Analytical and Clinical Perspectives on Amylase — StatPearls, NCBI Bookshelf (NIH)
- Pancreatic Function Assessment — PubMed (2014)
- The Role of Magnesium in Pancreatic Beta-Cell Function and Homeostasis — PMC (2024)
- Zinc Transporters and Their Role in the Pancreatic β-Cell — PMC (2014)
- Zinc and Insulin in Pancreatic Beta-Cells — PubMed (2013)
- Intracellular Zinc in Insulin Secretion and Action: A Determinant of Diabetes Risk? — PubMed (2015)
- Chromium — Linus Pauling Institute, Oregon State University
- The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis — PMC (2021)
- Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis — PMC (2021)
- Effects of Berberine against Pancreatitis and Pancreatic Cancer — PMC (2022)
- The Metabolic Effect of Momordica charantia Cannot Be Determined Based on the Available Clinical Evidence: A Systematic Review and Meta-Analysis — PMC (2024)
- The Effect of Bitter Melon (Mormordica charantia) in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis — Nature/Nutrition & Diabetes (2014)
- Therapeutic Applications of Curcumin for Patients with Pancreatic Cancer — PMC (2014)
- Curcumin Anticancer Studies in Pancreatic Cancer — PMC (2016)
- Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition in Pancreatic Cancer Cells — PMC (2014)
Natural Remedies
Ingredients
These ingredients are often used in alternative medicine to support pancreas.
- 4-hydroxyisoleucineScientific
4-Hydroxyisoleucine is a unique amino acid found in fenugreek seeds that directly stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner. Animal studies show it upregulates insulin expression in pancreatic tissue, lowers blood glucose, and improves oral glucose tolerance. It is considered one of fenugreek's primary pancreas-active constituents.
- adzuki beanScientific
Adzuki bean polysaccharides improved pancreatic islet cell recovery in diabetic rodents in a dose-dependent manner. In vitro, black adzuki bean ethanolic extract stimulated significantly greater insulin secretion from pancreatic β-cells (RINm5F cells) under glucose challenge. Adzuki bean's low GI and alpha-glucosidase inhibition also reduces demand on pancreatic insulin output.
- akkermansia muciniphilaScientific
A. muciniphila signatures have been detected in human pancreatic tissue, and its metabolites (propionate) and protein P9 stimulate insulin secretion from pancreatic beta-cells and GLP-1 from intestinal L-cells. In vitro studies confirm A. muciniphila cell extracts stimulate pancreatic beta-cell insulin secretion. Human correlation data show inverse associations between A. muciniphila abundance and conditions of pancreatic beta-cell dysfunction, including type 2 diabetes.
- ALA (alpha-lipoic acid)Scientific
Alpha-lipoic acid (ALA) is a naturally occurring dithiol antioxidant that protects pancreatic islet cells from oxidative stress-induced damage. Animal studies show ALA supplementation prevents severe damage to pancreatic beta cells in diabetic models and preserves insulin expression. It reduces plasma glucose and HbA1c by acting as a potent antioxidant in islet tissue.
- AlluloseScientific
Animal and human studies suggest allulose helps preserve pancreatic beta-cell structure and endogenous insulin secretory capacity. A human crossover trial in type 2 diabetics found reduced insulin requirement with allulose intake, consistent with reported beta-cell protective effects seen in diabetic rat models.
- almondScientific
Almonds influence pancreatic function primarily through their effects on insulin secretion and glycemic response. RCTs show that almonds consumed before or with meals blunt postprandial glucose and insulin spikes, reducing beta-cell demand. In pre-diabetic adolescents, almond consumption was associated with reduced stimulated insulin levels, suggesting improved pancreatic efficiency.
- aloe veraScientific
Aloe vera demonstrates significant effects on pancreatic function through its documented ability to improve insulin sensitivity and potentially enhance pancreatic beta-cell activity. A meta-analysis of five RCTs found aloe vera significantly reduced HbA1c and fasting glucose, suggesting sustained improvement in pancreatic insulin regulation.
- alpinia galangalScientific
A. galanga extracts protect pancreatic beta cells from oxidative stress and improve insulin secretion in animal models of diabetes. Histopathological improvement in pancreatic tissue has been documented in multiple STZ/alloxan diabetic rodent studies. Galangin normalises plasma insulin levels in insulin-resistant models.
- AMPK (AMP-activated protein kinase)Scientific
AMPK is a key energy-sensing enzyme in pancreatic cells that regulates insulin secretion, beta cell survival, and responses to glucose. AMPK activation in pancreatic tissue protects beta cells under metabolic stress conditions. Multiple validated pancreas-supportive compounds (berberine, metformin, resveratrol, ALA) work through AMPK activation as a primary mechanism.
- amylaseScientific
The pancreas is the primary production site of alpha-amylase (AMY2), secreting it into the duodenum as the dominant digestive amylase in adults. Pancreatic disease impairs amylase output, and amylase-containing PERT is the cornerstone treatment for exocrine pancreatic insufficiency from any etiology.
- amylopectinScientific
The pancreas is directly involved in amylopectin metabolism via two distinct mechanisms: its exocrine function (secretion of pancreatic amylase into the duodenum to digest amylopectin) and its endocrine function (beta-cell insulin secretion in response to the rapid blood glucose rise caused by amylopectin's high GI). Chronic high amylopectin intake has been hypothesized to increase pancreatic beta-cell demand, with animal studies linking long-term high-amylopectin diets to elevated insulin responses and pancreatic stress.
- anemarrhena asphodeloidesScientific
Anemarrhena ethanol extract directly stimulates insulin secretion from pancreatic beta cells in isolated islets of both normal and diabetic rats. Mangiferin reduces insulin resistance and improves beta-cell function markers. The traditional use of the herb for diabetes is supported by multiple pancreatic-level mechanisms.
- apple cider vinegarScientific
ACV's effects on pancreatic function are evidenced by clinical improvements in postprandial insulin secretion, HOMA-B (beta-cell function), and glucose homeostasis in T2DM patients. The mechanism involves reduced demand on pancreatic beta cells due to lower postprandial glucose loads from ACV's gastric-emptying delay and enzyme inhibition.
- artichokeScientific
Artichoke leaf extract inhibits pancreatic lipase and amylase activity in preclinical models, modulating digestive enzyme secretion and reducing caloric substrate absorption. Inulin from artichoke may enhance GLP-1-driven beta-cell function and insulin secretion. These effects intersect with pancreatic exocrine and endocrine function.
- ashitabaScientific
Ashitaba chalcones lower blood glucose and serum insulin in diabetic mouse models, suggesting reduced pancreatic β-cell demand. XA and 4-HD inhibit α-glucosidase and activate AMPK, reducing post-prandial glucose load and insulin secretion requirements. No direct pancreatic histology studies specific to ashitaba are published.
- banabaScientific
Banaba (Lagerstroemia speciosa) leaf extracts have been used in Filipino folk medicine for diabetes since at least 1940. Corosolic acid and ellagitannins including lagerstroemin exhibit insulin-like glucose uptake activity and insulin receptor activation. A clinical study with standardized corosolic acid extract showed a 30% reduction in blood glucose in type 2 diabetic subjects.
- barberryScientific
Barberry extract has been shown to increase insulin secretion from pancreatic islets in experimental models, and clinical trials show improvements in insulin levels. Berberine's mechanisms include stimulation of pancreatic beta cell function and inhibition of intestinal glucose absorption.
- barleyScientific
Barley β-glucan reduces pancreatic β-cell insulin secretory demand by blunting postprandial glucose spikes. Clinical trials in type-2 diabetic patients show reduced postprandial C-peptide (marker of insulin secretion) following barley consumption, suggesting reduced pancreatic workload.
- berberineScientific
Berberine has been extensively studied for its effects on pancreatic beta cells, demonstrating promotion of beta cell regeneration, improved insulin secretion, and protection against beta cell apoptosis in animal and clinical models. Multiple human trials have shown it reduces fasting blood glucose and HbA1c comparably to metformin. Its primary mechanism involves AMPK activation and inhibition of mitochondrial complex I.
- beta-alanineScientific
Meta-analytic evidence from human RCTs shows that carnosine or BA supplementation improves HOMA-β, a marker of pancreatic β-cell function, in people with prediabetes or type 2 diabetes. A 2025 meta-analysis (8 RCTs, n=377) found significant improvement in HOMA-β alongside reductions in fasting blood glucose and HbA1c, suggesting a beneficial effect on β-cell secretory capacity or survival.
- bile saltScientific
Bile salts are required to activate bile salt-stimulated lipase (BSDL/BSSL), a pancreatic enzyme that catalyzes hydrolysis of dietary lipid esters and cholesterol esters in the duodenum. Bile salts protect sterol ester hydrolase from tryptic inactivation. In pancreatic exocrine insufficiency (PEI), co-administration of bile acid supplements with pancreatin has been shown in clinical trials to improve fat absorption above enzyme replacement alone.
- black cuminScientific
Multiple RCTs and meta-analyses confirm N. sativa improves pancreatic β-cell function (assessed by HOMA-β) and C-peptide levels in type-2 diabetic patients. A one-year trial documented significantly higher β-cell activity in the N. sativa group. TQ protects β-cells from oxidative stress-induced apoptosis.
- blackboard treeScientific
Preclinical studies in STZ-induced diabetic rats show that A. scholaris bark and leaf extracts protect pancreatic tissue. Histopathological analysis in treated diabetic rats reveals preserved islets of Langerhans, and alpha-glucosidase inhibition has been demonstrated in vitro.
- blueberryScientific
Blueberry bioactives interact with pancreatic function via modulation of glucose-stimulated insulin secretion and protection of beta-cell function. A clinical study in T2DM volunteers found a bilberry extract significantly reduced glucose and insulin AUC, implicating pancreatic beta-cell effects.
- butyric acidScientific
Butyrate protects pancreatic beta cells from cytokine-induced dysfunction via HDAC inhibition and anti-inflammatory gene regulation. In autoimmune diabetes models, butyrate-induced Tregs migrate from gut to pancreatic islets to restore immune tolerance.
- caesalpinia cristaScientific
C. crista seed extracts have shown evidence of pancreatic beta cell protection and insulin secretagogue activity in preclinical diabetic models. Histopathological studies showed altered islet structure in diabetic animals treated with extracts, and isolated fractions increased insulin secretion from isolated islets.
- caryophylleneScientific
CB2 receptors regulate calcium signaling and insulin secretion in pancreatic beta-cells. BCP has been shown to protect beta-cells from hyperglycemia-induced damage and enhance insulin/glucose signaling in preclinical models.
- cassia barkScientific
Animal studies demonstrate that C. cassia extract directly affects pancreatic tissue in diabetic models, restoring beta-cell histology and serum amylase levels. Proposed mechanisms include insulin secretagogue activity and pancreatic beta-cell protection.
- catechinsScientific
Catechins protect pancreatic beta cells from cytokine-induced oxidative damage via NF-κB and NLRP3 inhibition. They also influence incretin hormone secretion from intestinal K and L cells. Evidence supports improved beta-cell function and glucose-stimulated insulin secretion with catechin supplementation in metabolically compromised populations.
- catjang cowpeaScientific
Cowpea bioactive peptides and phenolics influence pancreatic enzyme activity and insulin-related signaling. Inhibition of pancreatic α-amylase by cowpea protein hydrolysates has been demonstrated in vitro, and cowpea's low GI reduces pancreatic insulin demand. An insulin-homologous protein has been isolated from cowpea seeds.
- charantinScientific
Charantin is the primary hypoglycemic steroidal saponin constituent of bitter melon (Momordica charantia) that exhibits insulin-mimetic activity and stimulates insulin secretion from pancreatic beta cells. It has been identified as a key compound responsible for bitter melon's clinically documented anti-diabetic effects. Studies show it increases glucose uptake and GLUT-4 translocation.
- chia seedScientific
Chia seeds reduce postprandial glucose spikes by 22–30% via mucilage-mediated slowing of carbohydrate absorption, thereby reducing the insulin secretion demand on beta cells. This pancreatic 'sparing' effect is supported by RCT evidence in type 2 diabetic and overweight populations.
- chickpea proteinScientific
Chickpea protein hydrolysates contain DPP-IV inhibitory peptides that prolong active GLP-1, supporting pancreatic beta-cell function and insulin secretion. Preclinical studies show chickpea protein hydrolysate modulates gene expression in pancreatic tissue under high-fat-diet conditions. Alpha-glucosidase inhibitory activity reduces the glycaemic load presented to the pancreas after meals.
- chromic chlorideScientific
Chromium's interaction with pancreatic beta-cell function has been studied in the context of insulin resistance and PCOS. One trial in PCOS patients found chromium supplementation improved a measure of beta-cell function. A mechanistic paper proposes that chromium's insulin-sensitizing effect down-regulates beta-cell secretory activity, potentially enhancing glucagon secretion from alpha cells. Chromium accumulates in pancreatic tissue in animal models.
- chromiumScientific
Chromium is an essential trace mineral that supports pancreatic function by enhancing insulin receptor sensitivity and potentiating insulin action. Clinical studies show chromium supplementation decreases fasting blood glucose, improves glucose tolerance, and lowers insulin levels in diabetic subjects. It is a critical cofactor in the glucose tolerance factor (GTF) complex.
- chymotrypsinScientific
The pancreas is the endogenous source of chymotrypsin: it synthesizes and secretes chymotrypsinogen (the inactive precursor) as part of its exocrine digestive function. Fecal chymotrypsin measurement is used diagnostically to assess pancreatic exocrine sufficiency. Chymotrypsin isoforms also play a protective role in the pancreas by degrading trypsinogens and limiting harmful trypsin activation.
- cinnamonScientific
Cinnamon and its bioactive cinnamaldehyde help regulate blood sugar by improving insulin sensitivity and reducing inflammation in pancreatic tissues. Rich in antioxidant polyphenols, it has been shown in clinical trials to reduce fasting blood glucose in type 2 diabetics. Traditional Chinese and Ayurvedic medicine have long used cinnamon for digestive and metabolic conditions.
- cloveScientific
Eugenol from clove enhances insulin secretion and content from isolated pancreatic islets in ex vivo research, and protects pancreatic β-cells from dedifferentiation under high glucose and lipid stress. A human pilot study showed clove extract inhibited carbohydrate-digesting enzymes relevant to pancreatic load.
- cocoaScientific
Cocoa polyphenols may induce pancreatic β-cell regeneration, stimulate insulin secretion, and have a hypoglycaemic effect. Clinical evidence shows significant improvements in fasting insulin and HOMA-IR in meta-analyses of RCTs. Pancreatic protection is proposed via antioxidant reduction of oxidative stress in β-cells.
- coixScientific
Coix prolamin hydrolysates inhibit DPP-IV—a pancreas-relevant enzyme—and improve insulin secretion dynamics in T2DM mouse models. Coix polysaccharides increase serum insulin levels while reducing glucose, suggesting beta-cell or insulin secretion support.
- coptis chinensisScientific
Berberine from Coptis chinensis protects pancreatic beta-cells, enhances insulin secretion, and increases peripheral insulin sensitivity. These effects are confirmed in multiple RCTs and mechanistic studies. The herb is a core component of classic TCM anti-diabetic formulas targeting the pancreatic-metabolic axis.
- CoQ10 (coenzyme Q10)Scientific
CoQ10 is naturally concentrated in the pancreas, where it supports mitochondrial ATP generation essential for glucose-stimulated insulin secretion in beta cells. Clinical evidence from RCTs in T2DM and prediabetes demonstrates improved glycemic control and HOMA-IR, consistent with protection of pancreatic beta cell function. Oxidative stress-mediated beta cell apoptosis is a key mechanism CoQ10 is proposed to counteract.
- cordycepsScientific
Cordyceps extracts stimulate pancreatic insulin secretion via cholinergic mechanisms and support beta-cell function in preclinical models. C. militaris extract induced additional insulin secretion by 54.5% in normal rats via cholinergic pathways. Cordyceps has also been shown to reduce HOMA-IR and serum glucose in diabetic mouse models, suggesting broader pancreatic and peripheral insulin-signaling support.
- cornScientific
Corn silk extracts and soluble corn fiber have evidence of modulating pancreatic beta-cell function through improved insulin secretion and glycemic response in animal and human studies. Corn silk flavonoids in diabetic animals improved blood glucose control, with proposed mechanisms including beta-cell protection and incretin modulation.
- cornsilkScientific
Corn silk extract has been shown in multiple preclinical studies to support pancreatic function by promoting insulin secretion, partially recovering alloxan-damaged beta-cells, and protecting beta-cells from glucotoxicity. These effects are mediated by flavonoids, polysaccharides, and phenolic acids that reduce beta-cell oxidative stress and support insulin gene expression.
- cuminScientific
Animal studies show cumin modulates pancreatic enzyme activity including lipase, amylase, trypsin, and chymotrypsin. RCTs in diabetic patients demonstrate cumin reduces HbA1c and improves insulin metabolism markers, implicating pancreatic beta-cell function. Mechanistic evidence is from animal models; human pancreatic enzyme studies are lacking.
- curcuminScientific
Curcumin, the main polyphenol in turmeric, protects pancreatic beta cells from oxidative stress, high-glucose-induced apoptosis, and inflammation through multiple signaling pathways. It has been shown to reverse STZ-induced damage to pancreatic islets in animal models. A clinical study found curcumin supplementation significantly delayed progression to type 2 diabetes in a pre-diabetic population.
- daidzinScientific
Daidzein/daidzin support pancreatic beta-cell function in animal models of diabetes, preventing insulin deficiency and preserving insulin secretion capacity. Mechanisms include inhibition of alpha-glucosidase and modulation of pancreatic glucokinase activity. Evidence is preclinical.
- EGCG (epigallocatechin gallate)Scientific
EGCG enhances pancreatic β-cell function, improves insulin secretion, protects β-cells from high-glucose-induced mitochondrial apoptosis, and has shown promise against pancreatic cancer in preclinical studies. Meta-analyses of RCTs show modest antihyperglycemic effects.
- enicostemma littoraleScientific
E. littorale and swertiamarin directly target pancreatic beta cells, enhancing glucose-induced insulin secretion through a K⁺-ATP channel-dependent pathway. Swertiamarin has been shown to prevent STZ-induced beta cell damage and promote beta cell regeneration in rat models. Molecular studies link E. littorale phytochemicals to glucokinase activation.
- exopeptidaseScientific
The exocrine pancreas is a primary source of endogenous exopeptidases, specifically carboxypeptidases A and B, which it secretes as inactive zymogens activated in the duodenum. These pancreatic exopeptidases are essential for terminal protein digestion and are depleted in exocrine pancreatic insufficiency. Clinical management of pancreatic exocrine dysfunction includes enzyme replacement that restores exopeptidase activity.
- fenugreekScientific
Fenugreek seeds contain 4-hydroxyisoleucine, trigonelline, and galactomannan, which stimulate pancreatic beta cell activity and insulin secretion. Animal studies show fenugreek administration upregulates insulin expression in pancreatic tissue. Human clinical trials document reductions in fasting blood glucose and HbA1c.
- ferulic acidScientific
Ferulic acid protects pancreatic β-cells from inflammatory and oxidative damage (via NF-κB inhibition), stimulates insulin secretion, promotes glucokinase activity, and inhibits STZ-induced β-cell toxicity in preclinical models. These actions directly support pancreatic function in glucose homeostasis. Evidence is preclinical; no dedicated human pancreatic-endpoint trials exist.
- fisetinScientific
Fisetin protects pancreatic beta cells from oxidative and glucotoxic damage in diabetic models, improves insulin secretion, and normalizes fasting insulin levels in type 1 diabetic rats. These effects relate to its Nrf2 antioxidant and anti-inflammatory mechanisms.
- fish oilScientific
Fish oil omega-3s influence pancreatic function through PPAR-γ activation in beta cells, reduction of inflammatory cytokines (TNF-α, IL-1β) that impair insulin secretion, and improvement of beta cell membrane composition. Clinical evidence shows fish oil improves HbA1c and insulin-related parameters in T2DM patients, supporting a role in beta cell protection and insulin secretory function.
- flosin BScientific
Flosin B is an ellagitannin isolated from Banaba (Lagerstroemia speciosa) that has been shown to increase glucose uptake in isolated rat adipocytes alongside lagerstroemin and reginin. It is one of three ellagitannins specifically extracted from Banaba leaves identified as active in glucose metabolism. Evidence derives from in vitro cell culture studies.
- fu lingScientific
Poria cocos is among the top 10 herbs used for type 2 diabetes in China, with a PLOS ONE meta-analysis of 73 RCTs showing significant reductions in fasting glucose, postprandial glucose, and HbA1c. Triterpenes activate PPAR-γ in pancreatic and adipose contexts. These effects imply modulation of pancreatic insulin secretion or peripheral insulin sensitivity.
- gamma oryzanolScientific
Gamma oryzanol enhances pancreatic insulin secretion and protects beta cell function in preclinical diabetes models. A 2025 systematic review confirmed that improved insulin secretion from pancreatic beta cells is among gamma oryzanol's documented glycaemic mechanisms. This contributes to its glucose-lowering effects.
- ganodermaScientific
Ganoderma lucidum protects pancreatic β-cells from oxidative stress-induced damage, maintains insulin production, and improves insulin secretion. These effects are evidenced preclinically and supported by clinical data on glucose and insulin parameters.
- garbanzo beanScientific
Garbanzo beans reduce the glycemic and insulinemic demand on the pancreas. Their low glycemic index, resistant starch, and soluble fiber slow carbohydrate digestion and absorption, blunting postprandial glucose spikes and reducing the compensatory insulin secretion burden on pancreatic beta cells. This effect is well-documented across multiple controlled crossover trials.
- gardeniaScientific
Gardenia jasminoides protects pancreatic tissue in both acute pancreatitis and diabetic models. GJ extract reduced pancreatic inflammation, serum amylase and lipase, and TNF-α/IL-1β/IL-6 in cerulein-induced acute pancreatitis in mice. Genipin restores insulin-secreting beta-cell function impaired by obesity and hyperglycemia via UCP2 inhibition.
- gardenia jasminoidesScientific
Gardenia jasminoides protects the pancreas on two fronts: it demonstrated significant protection against cerulein-induced acute pancreatitis in mice, and geniposide protects pancreatic beta cells by inhibiting UCP2 to restore insulin secretory function in diabetic models. Geniposide also ameliorated acinar cell injury in a 2025 in vitro/in vivo study.
- garlic bulbScientific
Garlic compounds protect pancreatic beta-cells from oxidative damage, stimulate insulin secretion, and improve insulin sensitivity, as documented in clinical trials and mechanistic studies. The hypoglycemic action includes increased pancreatic insulin secretion from beta-cells and release of bound insulin.
- genisteinScientific
Genistein has documented effects on pancreatic beta-cell function, stimulating insulin secretion, promoting beta-cell proliferation, and protecting against beta-cell apoptosis. Preclinical data are strong; clinical RCTs in T2DM patients show improved glucose and insulin parameters consistent with enhanced beta-cell function.
- gingerScientific
Ginger influences pancreatic function primarily through protection of insulin-producing beta cells from oxidative stress and improvement of insulin secretion efficiency. Clinical data show improved insulin levels and reduced HOMA-IR with ginger supplementation. Ginger is also proposed to stimulate pancreatic enzyme release into the small intestine.
- ginsengScientific
Ginseng (Panax ginseng) and its ginsenosides enhance insulin secretion, protect pancreatic beta cells from damage, and improve glucose tolerance. Animal studies show Korean red ginseng ameliorates cyclosporine-induced pancreatic beta cell injury. Traditional Chinese and Korean medicine have used ginseng for over 2,000 years for various metabolic conditions.
- ginsenosidesScientific
Ginsenosides, the principal bioactive saponins of ginseng, exhibit anti-diabetic properties including enhancement of insulin secretion, improvement of glucose uptake, and protection of pancreatic beta cells from damage. They represent the pharmacologically active constituents underlying ginseng's pancreatic benefits. Multiple preclinical and clinical studies confirm these effects.
- glucoamylaseScientific
While glucoamylase itself is produced at the small intestinal brush border rather than the pancreas, it directly complements pancreatic amylase in starch digestion and becomes functionally more important when pancreatic exocrine output is compromised. The relationship is one of functional compensation.
- glucomannanScientific
Glucomannan indirectly reduces the secretory burden on pancreatic beta cells by slowing gastric emptying and glucose absorption, thereby dampening postprandial insulin demand. The 2023 meta-analysis confirmed significant reductions in fasting insulin in T2DM patients. In vitro work with konjac oligosaccharides has also examined direct effects on pancreatic islet cells.
- grapefruitScientific
Naringenin from grapefruit has shown protective effects on pancreatic tissue in diabetic animal models, including increased pancreatic antioxidant enzyme activities and reduced oxidative damage. Clinical subgroup data show grapefruit consumption reduces 2-hour insulin levels in metabolic syndrome patients, suggesting effects on pancreatic beta-cell demand. Evidence in humans specific to pancreatic tissue protection is preclinical.
- green chirettaScientific
Green chiretta has demonstrated protective effects on pancreatic beta cells in diabetic models. Preclinical studies show andrographolide reduces beta-cell dysfunction, improves insulin secretion, and upregulates GLUT-4 expression relevant to pancreatic function in glucose regulation.
- green teaScientific
Green tea catechins, particularly EGCG, influence pancreatic beta-cell function and insulin secretion through effects on glucose metabolism. A meta-analysis of 9 cohort studies found green tea consumption ≥4 cups/day was associated with a significant reduction in type 2 diabetes risk (RR 0.80), implicating protection of pancreatic function. EGCG modulates GLUT4-mediated glucose uptake in insulin-sensitive tissues, reducing the burden on pancreatic beta cells.
- gymnema sylvestreScientific
Gymnema sylvestre has been used in Ayurvedic medicine for over 2,000 years to treat diabetes. Its active gymnemic acids stimulate insulin secretion from pancreatic beta cells and have been shown to regenerate beta cells in animal models. Clinical trials have demonstrated reductions in fasting blood glucose and HbA1c in type 2 diabetic patients.
- gymnemic acidsScientific
Gymnemic acids are the principal bioactive triterpenoid saponins of Gymnema sylvestre responsible for its pancreatic effects. They stimulate insulin secretion from pancreatic beta cells and have shown beta cell regenerative effects in animal models. They are the pharmacologically active fraction underlying Gymnema sylvestre's clinically documented anti-diabetic activity.
- hesperetinScientific
Hesperetin/hesperidin demonstrates glucose-lowering and insulin-modulating effects in animal models of diabetes, with some human RCT evidence for insulin level reduction at doses ≥1,000 mg/day. Effects involve pancreatic beta-cell protection and anti-inflammatory mechanisms that reduce insulin resistance.
- indian baelScientific
Multiple animal studies demonstrate that Aegle marmelos fruit and leaf extracts protect pancreatic beta cells from STZ-induced damage, enhance insulin secretion, preserve beta-cell integrity, and modulate pancreatic morphology — positioning the pancreas as a key organ target of bael's antidiabetic mechanism.
- indian tinosporaScientific
T. cordifolia interacts with pancreatic function through enhancement of insulin secretion from beta cells and modulation of glucose metabolism pathways. Preclinical studies demonstrate protection of pancreatic beta cells in diabetic models, increased insulin secretion, and AMPK-mediated glucose uptake independent of insulin. Clinical antidiabetic data are consistent with pancreatic mechanisms.
- inositolScientific
Inositol functions as a second messenger in insulin receptor signaling and improves pancreatic beta-cell sensitivity to glucose. Clinical evidence across multiple RCTs and meta-analyses consistently demonstrates reductions in fasting insulin, HOMA-IR, and AUC insulin with inositol supplementation, indicating improved pancreatic insulin dynamics. Effects are most established in insulin-resistant populations (PCOS, metabolic syndrome, prediabetes).
- inulinScientific
Inulin indirectly supports pancreatic beta-cell function by improving glucose homeostasis and reducing ectopic pancreatic fat deposition, observed in an MRI-based RCT in prediabetic subjects. SCFA-driven GLP-1 secretion from intestinal L-cells also potentiates insulin release from pancreatic beta cells.
- jiaogulanScientific
Animal studies show jiaogulan preserves pancreatic beta-cell function and insulin production in diabetic mice, and may stimulate additional insulin secretion. Human clinical trials confirm improved insulin sensitivity in type 2 diabetic patients, with the pancreas as an indirect target.
- kidney beansScientific
Kidney beans reduce pancreatic demand for insulin by slowing starch digestion and limiting the postprandial glucose surge. The alpha-amylase inhibitor phaseolamin directly inhibits pancreatic alpha-amylase enzyme activity, modulating the rate of carbohydrate breakdown before glucose reaches the bloodstream.
- L-alanineScientific
L-Alanine is a recognised stimulus for insulin secretion from pancreatic beta cells and serves as a metabolic fuel for islet tissue. Animal studies show that L-alanine supplementation can regenerate islets of Langerhans damaged by alloxan. It is consumed by pancreatic beta cells and plays a functional role in stimulus-secretion coupling.
- L-glycineScientific
Glycine stimulates insulin secretion from pancreatic beta cells and may protect beta-cell function from oxidative stress via glutathione synthesis. Clinical studies show that oral glycine increases insulin secretory responses. Low plasma glycine is associated with impaired beta-cell function in the context of type 2 diabetes and metabolic syndrome.
- L-leucineScientific
The pancreatic β-cell is a major direct target of leucine. Leucine is one of only a few amino acids capable of independently initiating β-cell electrical activity and insulin secretion, doing so via KATP channel modulation and GDH allosteric activation. Human clinical studies confirm leucine's insulinotropic effect, and long-term leucine treatment of T2DM patient islets improves insulin secretory function.
- lagerstroeminScientific
Lagerstroemin is an ellagitannin isolated from Banaba (Lagerstroemia speciosa) that activates insulin receptors, increases glucose uptake in adipocytes, and activates ERK signaling pathways relevant to glucose metabolism. It is one of the identified active constituents responsible for Banaba's traditional anti-diabetic effects. Evidence is primarily from in vitro studies.
- lipaseScientific
The pancreas is the primary source of lipase in digestion, and pancreatic lipase is the rate-limiting enzyme for dietary fat digestion. Diseases of the pancreas (chronic pancreatitis, cystic fibrosis, pancreatic cancer, necrotizing pancreatitis) that reduce exocrine output are the principal clinical indication for lipase supplementation. RCT evidence is extensive.
- luteolinScientific
Luteolin protects pancreatic beta cells from inflammatory and oxidative damage in preclinical diabetes models, improving insulin secretion and reducing hyperglycemia. Its effects on insulin signaling and beta cell function are documented in STZ and diet-induced models.
- magnesiumScientific
Magnesium is required for normal pancreatic β-cell function and insulin secretion. Deficiency disrupts ATP-sensitive potassium channel activity in β-cells, impairing insulin release. Conversely, excess calcium influx under low Mg conditions stimulates inappropriate insulin secretion, contributing to hyperinsulinemia. Magnesium also plays a role in pancreatic exocrine enzyme activity.
- maitake mushroomScientific
In type 2 diabetic animal models, maitake alpha-glucan treatment improved insulin receptor binding on liver membranes and reduced histopathological changes in pancreatic tissue. Maitake's insulin-sensitizing effects reduce compensatory pancreatic beta-cell workload by lowering peripheral insulin demand.
- manganeseScientific
The pancreas is a primary site of manganese storage in the body. Manganese deficiency impairs pancreatic insulin synthesis and secretion in animal models, and human epidemiological data consistently link lower blood manganese to higher rates of diabetes.
- mangoScientific
Mango polyphenols, particularly mangiferin, and dietary fiber modulate pancreatic function by inhibiting α-amylase and α-glucosidase activity, reducing postprandial glucose load, and thereby reducing pancreatic insulin demand. Human RCTs demonstrate improved insulin secretion patterns and glycemic control relevant to pancreatic beta-cell function.
- maqui berryScientific
Maqui berry's delphinidins modulate postprandial insulin secretion from pancreatic beta cells, as demonstrated across multiple human clinical trials. By attenuating glucose absorption via SGLT1 inhibition, maqui reduces the glycemic load on beta cells, potentially preserving their function in prediabetic states.
- MCT (medium chain triglycerides)Scientific
MCTs are uniquely advantageous in pancreatic insufficiency because their digestion does not require pancreatic lipase—residual gastric lipase activity is sufficient for hydrolysis. MCTs also minimally stimulate CCK secretion, potentially reducing postprandial pancreatic stimulation and associated pain in chronic pancreatitis.
- milk thistleScientific
Silymarin directly protects pancreatic beta cells from cytokine-induced destruction by blocking the ERK1/2 and NF-κB signaling pathways, reducing nitric oxide production. This mechanism is supported by published in vitro studies using human beta cell lines, and is consistent with the glycemic improvements observed in clinical RCTs of type 2 diabetes.
- millet seedScientific
Millet seed's low glycemic index and fiber content reduce post-prandial glucose excursions, decreasing pancreatic insulin secretion demand and preserving beta-cell function. Clinical trials show reduced insulin resistance and improved insulin sensitivity with millet consumption. Millet polyphenols also inhibit alpha-glucosidase and alpha-amylase, reducing pancreatic hormonal burden.
- momordicaScientific
Momordica charantia (bitter melon) contains charantin, polypeptide-p, and vicine, which exhibit insulin-mimetic activity and improve pancreatic beta cell function. A 12-week RCT in prediabetic patients showed bitter melon extract reduced post-challenge blood glucose and glucagon levels. Meta-analyses of 8 RCTs confirm significant reductions in fasting blood glucose.
- monk fruitScientific
Multiple in vitro studies show that monk fruit extract and mogroside V directly stimulate insulin secretion from pancreatic beta cells and protect those cells from oxidative stress-induced damage. Zhou et al. (2009, PubMed PMID 21351724) demonstrated significant beta cell insulinotropic activity; a 2016 study (PMID 27413420) showed mogroside V-mediated beta cell protection under high-glucose conditions.
- morusScientific
Morus alba protects pancreatic beta-cell function indirectly by reducing postprandial glucose load (via α-glucosidase inhibition) and lowering chronic insulin demand, thereby preserving beta-cell mass and function. Animal studies show direct beta-cell protection by M. alba anthocyanins in diabetic models.
- mulberryScientific
Mulberry leaf extract demonstrably reduces insulin secretory demand on the pancreas through α-glucosidase inhibition, with multiple human RCTs showing 31–38% reductions in postprandial insulin. Mulberry polysaccharides also stimulate pancreatic insulin secretion in preclinical studies. Mulberry twig alkaloids have shown HbA1c-lowering efficacy comparable to acarbose in T2DM.
- naringinScientific
Naringin and naringenin improve pancreatic function in diabetic animal models by protecting β-cells from oxidative stress and inflammation, improving insulin secretion, and restoring pancreatic antioxidant enzymes. The mechanisms involve GLUT-4 activation and PPAR-γ agonism relevant to pancreatic insulin homeostasis. Evidence is predominantly preclinical.
- neem treeScientific
RCT data show that neem leaf extract reduces insulin resistance (HOMA-IR), HbA1c, fasting, and postprandial blood glucose in T2DM patients, supporting pancreatic beta-cell function and insulin dynamics. The proposed mechanism includes prevention of serotonin-mediated inhibition of insulin release, directly implicating pancreatic function.
- NMN (β-nicotinamide mononucleotide)Scientific
Animal studies demonstrate NMN restores pancreatic NAD+ in beta cells, improving insulin secretion in diabetic and aged models. A human intravenous NMN safety study confirmed no adverse effects on pancreatic metabolic markers. NMN is proposed to protect beta cell function through SIRT1/NAMPT-mediated NAD+ biosynthesis.
- nopalScientific
Nopal has documented effects on pancreatic function as reflected by insulin secretion and glucose metabolism. Human trials show reduced postprandial serum insulin in diabetic patients consuming broiled nopal stems, and reduced insulin levels after glucose tolerance testing in metabolic syndrome subjects. The cladodes' low glycemic index (32.5) and insulinemic index (36.1) reflect favorable pancreatic demand. Mechanistic evidence involves fiber-mediated slowing of glucose absorption reducing pancreatic beta-cell stimulation.
- oatScientific
Oat β-glucan reduces postprandial glucose absorption, lowering pancreatic insulin secretion demand. In T2DM, OBG supplementation has reduced fasting glucose and HbA1c. Reduced insulin demand may help preserve pancreatic beta-cell function over time.
- okraScientific
Okra flavonoids, particularly quercetin, protect pancreatic beta cells from oxidative stress, potentially preserving insulin secretory capacity. Animal studies show okra extract can repair injured beta cells, reduce beta cell loss, and boost insulin secretion. Modulation of pancreatic PPAR-α and PPAR-γ has been observed in preclinical settings.
- oleanolic acidScientific
OA protects and supports pancreatic beta-cell function by stimulating insulin secretion, increasing insulin mRNA and protein concentrations, protecting beta-cells from degeneration, and potentially enhancing islet survival in diabetic animal models.
- olive oilScientific
Olive oil's phenolics protect pancreatic beta cells from oxidative damage and inflammatory cytokine-mediated apoptosis, and support insulin secretion. Human dietary studies show EVOO reduces HbA1c and fasting glucose, indicating improved pancreatic beta cell output and efficiency. Olive polyphenols modulate genes related to beta cell function.
- omega-3 fatty acidsScientific
Omega-3 fatty acids have documented effects on pancreatic beta-cell function, including improved insulin secretion and beta-cell preservation. Clinical trials in T2DM patients show mixed effects, with some demonstrating significant improvement in beta-cell function. Very high triglycerides are also a risk factor for pancreatitis, and omega-3's TG-lowering effect is clinically relevant.
- onionScientific
Onion protects pancreatic beta cells from oxidative stress and stimulates insulin secretion. Anthocyanins in red onion play a significant role in insulin secretion and beta cell protection. Multiple preclinical and some clinical studies confirm onion's hypoglycemic activity through pancreatic mechanisms.
- ophiopogon rootScientific
Ophiopogon root oligosaccharides modulate pancreatic function by inhibiting glucagon secretion, increasing GLP-1 levels, and enhancing insulin activity. In T2DM rat models, OJO improved overall glucolipid metabolism through mechanisms involving pancreatic hormone regulation. This is preclinical evidence; no human trials exist.
- palmitoleic acidScientific
Palmitoleic acid has been shown to protect pancreatic beta cells from apoptosis induced by saturated fatty acids and glucose toxicity, and may stimulate beta cell proliferation, contrasting with the lipotoxic effects of its saturated counterpart palmitic acid.
- pancreatinScientific
Pancreatin is a standardized mixture of exocrine pancreatic enzymes (amylase, lipase, protease) used as enzyme replacement therapy in exocrine pancreatic insufficiency due to chronic pancreatitis, cystic fibrosis, and pancreatic surgery. A meta-analysis of 7 RCTs confirmed it significantly improves fat and nutrient absorption. It directly addresses pancreatic exocrine function deficiency.
- picrorhiza kurroaScientific
Multiple animal studies demonstrate that P. kurroa extract promotes pancreatic β-cell regeneration, enhances insulin secretion, and protects β-cells from STZ-induced damage. Histopathological evidence of improved pancreatic β-cell mass and plasma insulin restoration has been published in peer-reviewed journals.
- pomegranateScientific
Pomegranate may support pancreatic beta-cell function and insulin secretion. A 2025 meta-analysis of 34 RCTs found significant reductions in fasting blood glucose and insulin parameters, implying pancreatic and peripheral insulin axis benefit. Antioxidant protection of islet cells from oxidative stress is the primary proposed mechanism.
- pomeloScientific
Pomelo bioactives inhibit pancreatic lipase activity, directly reducing dietary fat absorption, and enhance insulin secretion. Naringenin and naringin improve pancreatic beta-cell function in diabetic animal models by reducing oxidative stress and inflammation in pancreatic tissue. Naringenin inhibits proliferation of pancreatic cancer cells in vitro.
- prickly pear cactusScientific
Human clinical trials and a systematic review confirm Opuntia cladodes can reduce postprandial insulin levels alongside blood glucose, suggesting an insulin-sensitizing rather than purely insulin-secreting mechanism. Betalains may also inhibit α-amylase and α-glucosidase, pancreatic digestive enzymes.
- psylliumScientific
Psyllium indirectly supports pancreatic function by blunting postprandial glucose surges, thereby reducing repeated insulin secretory demand on beta cells. Some clinical studies report modest increases in GLP-1 (an incretin that stimulates glucose-dependent insulin secretion from beta cells) following psyllium-containing meals. HOMA-IR reductions in meta-analyses reflect improved whole-body insulin sensitivity, lessening the chronic compensatory burden on pancreatic beta cells.
- pterocarpus marsupiumScientific
P. marsupium has the most direct evidence of any herbal agent for pancreatic beta-cell regeneration. Multiple studies confirm its flavonoids restore beta-cell populations and functional insulin secretion in alloxan- and streptozotocin-diabetic animals.
- pumpkinScientific
Pumpkin polysaccharides and antioxidant compounds have demonstrated protective effects on pancreatic beta cells in animal models, preventing alloxan- and streptozotocin-induced beta-cell destruction. The proposed mechanism involves antioxidant shielding of beta cells, preservation of insulin-secreting capacity, and increased serum insulin levels.
- purslaneScientific
Purslane has demonstrated antidiabetic effects in multiple RCTs, with reductions in fasting blood sugar confirmed by meta-analysis (16 RCTs, p<0.001), implying beneficial effects on pancreatic beta-cell function or insulin secretion/sensitivity. Animal studies specifically show improved pancreatic beta-cell morphology and function with purslane supplementation.
- quercetinScientific
Quercetin has been studied primarily in preclinical models for its effects on pancreatic beta-cell protection, insulin secretion, and antioxidant defense in the pancreas. Animal studies show quercetin increases pancreatic insulin content, enhances antioxidant enzyme activities, and maintains viable beta-cell mass in diabetic models. Human RCT-level evidence specifically targeting the pancreas is not available, but human studies on blood glucose reduction have been meta-analyzed.
- quinoaScientific
Clinical evidence shows quinoa improves insulin resistance index and lowers postprandial blood glucose in pre-diabetic subjects, indicating reduced pancreatic beta-cell stress. A comprehensive review proposed mechanisms including reduced glucagon secretion, increased insulin secretion, and beta-cell protection. Animal studies show quinoa bioactive compounds modulate pancreatic glucose and lipid homeostasis.
- reginin AScientific
Reginin A is an ellagitannin from Banaba (Lagerstroemia speciosa) that increases glucose uptake in isolated rat adipocytes alongside lagerstroemin and flosin B. It represents one of the identified active constituents contributing to Banaba's traditional anti-diabetic effects. Evidence is limited to in vitro studies on glucose transport activation.
- rehmannia glutinosaScientific
R. glutinosa polysaccharides and catalpol directly enhance pancreatic islet function, increasing insulin secretion and content. In diabetic mice, RGP significantly enhanced both basal and glucose-stimulated insulin secretion and improved islet insulin content. Histopathological studies show pancreatic morphological improvement with catalpol.
- resveratrolScientific
Resveratrol, a polyphenol found in grapes and berries, protects pancreatic beta cells from inflammatory cytokine-induced dysfunction and improves glucose-stimulated insulin secretion. It inhibits IL-1β-induced nitric oxide production in islets and enhances pancreatic β-cell function by inhibiting phosphodiesterase activity. Human trials have demonstrated improved glycemic control and insulin sensitivity.
- rhubarbScientific
Rhubarb has the strongest evidence base among TCM herbs for acute pancreatitis, supported by multiple RCTs, meta-analyses, and a 2026 best-evidence synthesis. It reduces serum amylase, inhibits trypsin synthesis, protects pancreatic acinar cells, and shortens hospital stay. Clinical guidelines in China incorporate rhubarb for acute pancreatitis management.
- rhubarb rootScientific
Multiple meta-analyses of RCTs document rhubarb root's beneficial effects on pancreatic inflammation in severe acute pancreatitis, including reduced mortality, shorter hospital and ICU stays, decreased abdominal pain duration, and lower inflammatory markers.
- robusta coffeeScientific
Chlorogenic acids and caffeine in robusta coffee have documented effects on pancreatic beta cell function. A mechanistic study (PMC 2023) demonstrated that caffeine improved insulin signalling under endoplasmic reticulum stress in pancreatic beta cells, while CGA protected beta cells by enhancing insulin receptor substrate-2 expression. Epidemiological data show lower incidence of type 2 diabetes in frequent coffee drinkers, consistent with pancreatic beta cell protection.
- royal jellyScientific
Animal studies show RJ reduces oxidative stress in pancreatic tissue (MDA lowering, antioxidant enzyme normalization), potentially protecting beta cells. Insulin-stimulating effects are documented in human RCTs. RJ's hypoglycemic mechanisms likely involve both pancreatic beta cell protection and peripheral insulin sensitization.
- ryeScientific
Rye-based diets reduce postprandial insulin secretion demand on the pancreas, potentially supporting beta-cell function. The 2025 meta-analysis of 31 RCTs found rye significantly reduces insulin AUC. One RCT in postmenopausal women found high-fiber rye bread enhanced insulin secretion, suggesting possible beta-cell stimulation. Reduced insulin demand from lower glycemic load may benefit long-term pancreatic function.
- silymarinScientific
Silymarin protects pancreatic beta cells from oxidative damage and reduces beta-cell inflammation, contributing to its clinically demonstrated glycemic benefits. Its effects on insulin secretion, fasting insulin levels, and insulin resistance are confirmed in multiple RCTs and meta-analyses. Pancreatitis-specific pancreatic anti-inflammatory effects are mechanistically plausible but not yet confirmed in dedicated large human trials.
- soursopScientific
Soursop extracts interact with pancreatic function by stimulating insulin secretion, acting in an insulin-like manner, and protecting pancreatic beta-cells from oxidative damage in diabetic animal models. These effects are demonstrated in rodent in vivo studies.
- soy isoflavonesScientific
Soy isoflavones influence pancreatic function indirectly by improving insulin sensitivity and reducing insulin secretion requirements. Genistein has been shown to act on pancreatic beta cells in preclinical studies, with supporting clinical evidence of improved HOMA-IR and fasting insulin.
- spinachScientific
Spinach thylakoids modulate pancreatic function indirectly by delaying fat digestion and increasing GLP-1 release from gut L-cells, which enhances glucose-dependent insulin secretion from pancreatic beta cells while reducing glucagon from alpha cells. Thylakoid supplementation also reduced postprandial insulin levels in clinical trials.
SPMs protect pancreatic acinar and beta cells from inflammatory destruction. Preclinical models of both pancreatitis and type 1/2 diabetes show SPM-mediated reduction in pancreatic inflammation. Resolvins reduce islet inflammation and preserve insulin secretory capacity.
- steviaScientific
Stevia directly interacts with pancreatic beta cells via TRPM5 channel activation, stimulating glucose-induced insulin release. Animal studies show stevia extract exerts hypoglycemic effects through PPARγ-dependent regulation and antioxidant protection of pancreatic tissue. Some human trials have demonstrated insulinotropic effects, though others find no acute insulin-stimulating effect at lower doses.
- steviol glycosidesScientific
Steviol glycosides and their metabolite steviol glucuronide enhance pancreatic beta-cell insulin secretion in a glucose-dependent manner via TRPM5 channel potentiation. Animal studies show SGs attenuate pancreatic tissue damage in diabetic models. Human metabolite research confirms the insulinotropic pathway is physiologically relevant.
- stigmasterolScientific
Stigmasterol protects pancreatic β-cells from glucolipotoxicity-induced dysfunction and apoptosis, and attenuates acute pancreatitis in mouse models by targeting ERK1 signaling to reduce acinar cell necrosis, lipase, and amylase elevations.
- sulforaphaneScientific
Sulforaphane protects pancreatic beta-cells from oxidative stress–driven apoptosis, enhances insulin secretion via AMPK/PI3K-AKT pathways, and improves glucose tolerance. Multiple human T2DM RCTs demonstrate pancreatic function improvements via glycemic biomarkers. SFN also modulates PPARγ relevant to pancreatic lipid metabolism.
- taurineScientific
Taurine supports pancreatic beta-cell function by enhancing insulin secretion and improving insulin signalling. Clinical RCTs show taurine supplementation reduces fasting insulin, HOMA-IR, and in some analyses fasting glucose and HbA1c, supporting its role in pancreatic metabolic function.
- tocotrienolsScientific
Tocotrienols have been proposed to protect pancreatic beta cells from oxidative stress-induced dysfunction, potentially preserving insulin secretory capacity in T2DM. RCTs showing improved fasting insulin and HOMA-IR in T2DM patients provide indirect clinical evidence of pancreatic benefit.
- trans-pterostilbeneScientific
Pterostilbene has been studied for beta-cell protection and glycemic regulation in rodent diabetes models, with conflicting findings. Some studies show improved glucose tolerance and beta-cell function via PPAR-α and antioxidant pathways; others show no benefit in polygenic beta-cell burnout models.
- trichosanthesScientific
Trichosanthes kirilowii and its constituents (polysaccharides, lectins, proteins) demonstrate hypoglycemic activity in animal models via pathways involving insulin receptor activation and pancreatic beta cell protection. TK polysaccharide suppressed pancreatic beta cell apoptosis in STZ-induced T1DM rats. TK has been identified as the most frequently used Chinese herb among type 2 diabetic patients.
- trypsinScientific
Trypsin is produced by the pancreas as trypsinogen and is the central serine protease of pancreatic exocrine function. Premature intra-pancreatic activation of trypsinogen is the established initiating mechanism of acute pancreatitis. The pancreas-trypsin relationship is fundamental, well-documented in physiology and pathology.
- turmericScientific
Turmeric and its active compound curcumin have been shown to protect pancreatic beta cells from oxidative stress and high-glucose-induced apoptosis, improve insulin sensitivity, and reduce inflammation in pancreatic tissues. Turmeric has been used in Ayurvedic and traditional Chinese medicine for metabolic conditions for over 3,000 years. A clinical trial showed curcumin from turmeric prevented progression to type 2 diabetes in prediabetics.
- vanadiumScientific
In animal models, vanadium compounds partially preserve and promote proliferation of pancreatic beta cells, depressing beta cell death and increasing islet insulin stores. These insulinotropic effects have been demonstrated in streptozotocin-diabetic rat models. Human evidence specific to beta-cell preservation is lacking.
- vanadyl sulfateScientific
Vanadyl sulfate, an inorganic vanadium compound, exhibits insulin-mimetic activity and has been shown in human clinical trials to suppress hepatic glucose production and improve peripheral insulin-mediated glucose disposal. Studies in type 2 diabetic subjects show it reduces fasting blood glucose. It acts at the post-receptor level in insulin signaling pathways.
- vitamin B1Scientific
Thiamine influences pancreatic exocrine function, and thiamine deficiency has been shown to impair pancreatic secretion and alter gut barrier integrity relevant to pancreatic physiology. Cholinergic signaling via thiamine-dependent acetylcholine production is critical for pancreatic acinar and ductal cell function.
- whey proteinScientific
Whey protein stimulates pancreatic beta-cell insulin secretion via incretin pathways (GLP-1 and GIP). Pre-meal whey consumption consistently increases plasma insulin and GLP-1 concentrations across multiple RCTs. Evidence in T2DM patients includes enhanced beta-cell function and reduced insulin clearance. Mechanistically, whey amino acids act as direct secretagogues on beta cells, supplementing incretin-mediated stimulation.
- xyloseScientific
D-xylose reduces the postprandial glycemic and insulinemic burden on the pancreas through sucrase inhibition. In a Korean human RCT, xylose-containing drinks produced significantly lower plasma insulin at 15 and 30 minutes and a lower insulin AUC. In vitro, D-xylose dose-dependently stimulated insulin secretion from INS-1 pancreatic β-cells. Rodent data additionally showed pancreatic tissue regeneration in diabetic animals supplemented with D-xylose.
- yerba mateScientific
Yerba mate's bioactive compounds inhibit pancreatic lipase activity, and its anti-glycation properties may protect pancreatic beta-cells from advanced glycation end-product damage. Human RCT data showing improvements in HOMA-IR and HbA1c in pre-diabetic subjects imply favorable effects on insulin secretion and pancreatic function.
- zincScientific
Zinc is an essential trace mineral found in the highest concentrations in pancreatic beta cells, where it is indispensable for insulin synthesis, storage, and secretion. It plays a structural role in insulin hexamer formation and modulates beta cell signaling. Multiple studies over 80 years link zinc status to pancreatic function and diabetes risk.
- bilberryTraditional
Bilberry leaf has been used traditionally across Europe as a hypoglycemic remedy since at least the 19th century, tied to its perceived effect on blood sugar regulation potentially involving pancreatic function. Early animal studies using dogs with surgical pancreatectomy informed this use. Modern mechanistic work focuses on AMPK and peripheral insulin sensitivity rather than direct pancreatic beta-cell effects.
- bovine pancreasTraditional
Bovine pancreas glandular extracts have been used since the early 20th century in glandular therapy, based on the principle that animal organ extracts support corresponding human organs. Practitioners of naturopathic and European biological medicine used bovine pancreatic extracts to support digestion and enzyme production. The enzyme-concentrated form (pancreatin) has pharmaceutical-grade clinical evidence for exocrine pancreatic insufficiency.
- dandelionTraditional
Dandelion's bitter constituents are traditionally considered to stimulate pancreatic enzyme secretion via vagal/bitter-receptor reflex. Traditional use includes stimulation of digestive secretions encompassing the pancreas. In vitro evidence for insulin secretion stimulation exists but has not been confirmed in human studies.
- gentian rootTraditional
Gentian root is traditionally regarded as a tonic for the pancreas in European and Asian herbal medicine, attributed to its stimulation of CCK secretion which triggers pancreatic enzyme output. Traditional references list gentian for pancreatitis and pancreatic support. The bitter-reflex mechanism directly involves CCK-mediated pancreatic enzyme secretion. No clinical study has evaluated gentian root specifically on pancreatic function.
- velvet beanTraditional
Animal studies and a 2025 meta-analysis document histological regeneration of pancreatic islet cells following MP extract treatment in diabetic rodent models. In vitro studies show alpha-glucosidase and alpha-amylase inhibition, consistent with indirect pancreatic demand reduction. No human pancreatic morphology or function data exist.